A Mechanistic Pharmacokinetic Model for Liver Transporter Substrates Under Liver Cirrhosis Conditions.
about
The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives.Role of Hepatic Drug Transporters in Drug Development.Unequivocal evidence supporting the segregated flow intestinal model that discriminates intestine versus liver first-pass removal with PBPK modeling.
P2860
A Mechanistic Pharmacokinetic Model for Liver Transporter Substrates Under Liver Cirrhosis Conditions.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A Mechanistic Pharmacokinetic ...... er Liver Cirrhosis Conditions.
@en
A Mechanistic Pharmacokinetic ...... er Liver Cirrhosis Conditions.
@nl
type
label
A Mechanistic Pharmacokinetic ...... er Liver Cirrhosis Conditions.
@en
A Mechanistic Pharmacokinetic ...... er Liver Cirrhosis Conditions.
@nl
prefLabel
A Mechanistic Pharmacokinetic ...... er Liver Cirrhosis Conditions.
@en
A Mechanistic Pharmacokinetic ...... er Liver Cirrhosis Conditions.
@nl
P2093
P2860
P356
P1476
A Mechanistic Pharmacokinetic ...... er Liver Cirrhosis Conditions.
@en
P2093
P2860
P304
P356
10.1002/PSP4.39
P577
2015-06-01T00:00:00Z